Skip to content
Dfnet logo
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
      • Thought Leadership
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Software Releases
    • Log out
Menu
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
      • Thought Leadership
    • User Community
  • About
    • Careers
  • Contact Us
  • My Account
  • My Account
    • Software Releases
    • Log out
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
    • Source Verification
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About Us
    • Careers
Menu
  • Services
  • eClinical Solutions
    • Electronic Data Capture (EDC)
    • Electronic Patient Reported Outcomes (ePRO)
    • Direct Data Capture (DDC)
    • Electronic Consent (eConsent)
    • Source Verification
  • Industries
    • Biotech & Pharma
    • CROs
    • Medical Devices
    • Research Organization
  • Partners
  • Resources
    • Clinical Data Management Solutions:
      Digital, Paper, or a Hybrid Approach?
    • Knowledge Hub
    • Blog
    • User Community
  • About Us
    • Careers
  • Contact Us
  • My Account
  • Contact Us
Menu
  • Contact Us
Schedule a Demo

Temperature-stable experimental tuberculosis vaccine enters clinical testing

  • Home
  • Blog
  • Temperature-stable experimental tuberculosis vaccine enters clinical testing

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. Continue reading on the National Institutes of Health website.

DF/Net has been working with the Infectious Disease Research Institute (IDRI) in Seattle since 2004: they were our second client! We’ve worked on phase I, II, and II vaccine projects in Central and South America, India, Africa, and the U.S, studying leishmaniasis, TB, flu, and leprosy. IDRI is is a Product Development Partner for the Bill & Melinda Gates Foundation Global Health Clinical Consortium (GHCC), for which DF/Net is a Preferred Provider.

DF/Net is honored to be working with IDRI on this project.

Share:

We’d Love to Tailor The Perfect Software + Services Solution For You

Orange dots
Book A Call Now
Dfnet logo
Linkedin Youtube

DFnet is a healthcare technology company that provides eClinical solutions, including electronic data capture, eSource, and data management services. We bring more flexibility, better data quality, and greater efficiency to clinical trials everywhere in the world.

2023 © DF/Net Research, Inc. All Rights Reserved

Company

  • About Us
  • Blog
  • Meet the team
  • Privacy Policy
  • Cookie Policy

Our Work

  • Solutions
  • Services
  • Industries
  • Resources

Stay in Touch

  • Contact Us
  • Schedule a Demo
  • Join the Community

We use cookies

This website automatically uses the cookies needed to optimize your navigation. To allow additional cookies used to personalize content relevant to you, click “YES, I ACCEPT.”

Yes, I accept
Learn More